Showing results (81-90 of 88) with videos related to
Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 88 results.
Pharmaceuticals (Basel, Switzerland)|November 27, 2021
Multiple Antitumor Molecular Mechanisms Are Activated by a Fully Synthetic and Stabilized Pharmaceutical Product Delivering the Active Compound Sulforaphane (SFX-01) in Preclinical Model of Human GlioblastomaAlessandro Colapietro, Alessandra Rossetti, Andrea Mancini, et al.Cells|July 29, 2023
Role of a Novel Heparanase Inhibitor on the Balance between Apoptosis and Autophagy in U87 Human Glioblastoma CellsValeria Manganelli, Roberta Misasi, Gloria Riitano, et al.Rheumatology (Oxford, England)|February 2, 2022
Carbamylation of β2-glycoprotein I generates new autoantigens for antiphospholipid syndrome: a new tool for diagnosis of 'seronegative' patientsAntonella Capozzi, Simona Truglia, Brigitta Buttari, et al.Frontiers in Pharmacology|October 5, 2020
The Botanical Drug PBI-05204, a Supercritical CO<sub>2</sub> Extract of Nerium Oleander, Inhibits Growth of Human Glioblastoma, Reduces Akt/mTOR Activities, and Modulates GSC Cell-Renewal PropertiesAlessandro Colapietro, Peiying Yang, Alessandra Rossetti, et al.Cancers|March 16, 2019
The Small Molecule Ephrin Receptor Inhibitor, GLPG1790, Reduces Renewal Capabilities of Cancer Stem Cells, Showing Anti-Tumour Efficacy on Preclinical Glioblastoma ModelsGiovanni Luca Gravina, Andrea Mancini, Alessandro Colapietro, et al.Cancers|December 31, 2025
RETRACTED: Gravina et al. The Small Molecule Ephrin Receptor Inhibitor, GLPG1790, Reduces Renewal Capabilities of Cancer Stem Cells, Showing Anti-Tumour Efficacy on Preclinical Glioblastoma Models. <i>Cancers</i> 2019, <i>11</i>, 359Giovanni Luca Gravina, Andrea Mancini, Alessandro Colapietro, et al.Journal of Oncology|March 19, 2020
Antitumorigenic Effects of Inhibiting Ephrin Receptor Kinase Signaling by GLPG1790 against Colorectal Cancer Cell Lines <i>In Vitro</i> and <i>In Vivo</i>Alessandro Colapietro, Giovanni Luca Gravina, Francesco Petragnano, et al.Journal of Translational Medicine|September 2, 2025
Validated methods for isolation and qualification of mesenchymal stromal/stem cells from different sourcesVincenzo Mattei, Francesca Santilli, Fanny Pulcini, et al.Pageof 9